Impact of fluoroquinolone treatment on delay of tuberculosis diagnosis: A systematic review and meta-analysis
Background: Fluoroquinolones are among the most commonly used antibiotics for the treatment of respiratory infections. Because fluoroquinolones show bactericidal activity against Mycobacterium tuberculosis, there is concern that their use can delay the diagnosis of tuberculosis. We conducted a syste...
Main Authors: | Catherine A Hogan, Lekha Puri, Genevieve Gore, Madhukar Pai |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-01-01
|
Series: | Journal of Clinical Tuberculosis and Other Mycobacterial Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405579416300419 |
Similar Items
-
Impact of molecular diagnostic tests on diagnostic and treatment delays in tuberculosis: a systematic review and meta-analysis
by: Jae Hyoung Lee, et al.
Published: (2022-12-01) -
Differential yield of universal versus selective drug susceptibility testing of patients with tuberculosis in high-burden countries: a systematic review and meta-analysis
by: Madhukar Pai, et al.
Published: (2020-10-01) -
Xpert MTB/RIF for tuberculosis testing: access and price in highly privatised health markets
by: Lekha Puri, et al.
Published: (2016-02-01) -
Mind the gap: Time to address implementation gaps in tuberculosis diagnosis and treatment
by: Madhukar Pai, et al.
Published: (2017-01-01) -
Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study Methodologies.
by: Samuel G Schumacher, et al.
Published: (2016-01-01)